Overall rank by patents
#42,245
of 49,997 tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Pardes Biosciences, Inc.
USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2021–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).
The verdict
According to USPTO PatentsView, Pardes ranks #42,245 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.
- #42,245
- of 49,997 US assignees by volume
- 33rd percentile
- by Innovation Score (30.2/100)
- 6.7
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R42245 · US Corporation #42,245 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 6 grants
- LOWER-Q #42,245/49,997
- PHOTO-FINISH Paradise Seed Pty
- CPC-NARROW C07D · 3 areas
- INNOV-THIN 30.2/100
- CLAIMS-SPARSE 6.7 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2021–2024 · 4y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Paradise Seed Company Pty Ltd (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Innovation-score neighbourhood around Pardes
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Pardes Biosciences · this assignee 30
Pardes Biosciences · this assignee
30 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Pardes's Innovation Score is 30.2/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Where Pardes's grants concentrate
Pardes Biosciences, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2024. By volume, Pardes sits between Paradise Seed Company Pty Ltd and Particle Dynamics International, LLC..
Pardes's three-year grant acceleration
Pardes Biosciences, Inc. shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Pardes's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Paradise Seed Pty
Paradise Seed Company Pty Ltd
6 patents
- Paragon Genomics
Paragon Genomics, Inc.
6 patents
- Paragon Water Sys…
Paragon Water Systems, Inc.
6 patents
- Pard Hardware Ind…
Pard Hardware Industrial Co., Ltd.
6 patents
- Paris Business Pr…
Paris Business Products, Inc.
6 patents
- Park Plus
Park Plus, Inc.
6 patents
- Parkling
Parkling GmbH
6 patents
- Particle Dynamics…
Particle Dynamics International, LLC.
6 patents
- Pardes Biosciences ◀
Pardes Biosciences, Inc.
6 patents
What this shows Pardes holds 6 patents at rank #42,341, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Pardes
By rank, the assignees closest to #42,341 in granted patent volume.
- Paradise Seed Company Pty Ltd #42,337 · 6 patents
- Paragon Genomics, Inc. #42,338 · 6 patents
- Paragon Water Systems, Inc. #42,339 · 6 patents
- Pard Hardware Industrial Co., Ltd. #42,340 · 6 patents
- Paris Business Products, Inc. #42,342 · 6 patents
- Park Plus, Inc. #42,343 · 6 patents
- Parkling GmbH #42,344 · 6 patents
- Particle Dynamics International, LLC. #42,345 · 6 patents
Leaders in C07D (Heterocyclic Compounds)
Other assignees with the most granted patents in Pardes's primary technology class.
Pardes's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 33rd percentile higher than 33% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 2 | 33.3% |
| 2022 | 3 | 50.0% |
| 2024 | 1 | 16.7% |
Which technologies does Pardes Biosciences, Inc. patent most?
Top 3 of 3 technology areas
What to do with this data
Pardes Biosciences, Inc.'s patent record in context - here's where to go next.
- Pardes Biosciences, Inc.'s lead technology class is C07D (Heterocyclic Compounds), 100% of its portfolio - see every assignee active in that class. Explore C07D
- Ranked #42,245 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Pardes Biosciences, Inc. against Paradise Seed Company Pty Ltd, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 30.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.